September 2021 – Page 2 – Boston Cambridge Biotech Networks

Insulet’s Omnipod® 5 Pivotal Study Extension Data Shows Significant Improvements in Glycemic Control With One Year of Use

September 30, 2021 bcbiotech Comments Off

ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, has presented positive pivotal trial extension phase results for the Omnipod® 5 Automated Insulin Delivery System (Omnipod 5). Omnipod 5, the world’s first tubeless, wearable system… Click here to view original post… […]

Phio Pharmaceuticals Announces Two Upcoming Data Presentations at Scientific Conferences in October 2021

September 30, 2021 bcbiotech Comments Off

MARLBOROUGH, Mass.: MARLBOROUGH, Mass., Sept. 30, 2021 /PRNewswire/ — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced two poster presentations at upcoming scientific conferences scheduled to take place in October 2021. These… Click here to view original post… […]

Moderna to Invest in New Science Center in Cambridge, MA

September 30, 2021 bcbiotech Comments Off

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna to invest in new science center in Cambridge, MA. Click here to view original post… […]

The Petri Dish: Ex-Moderna CMO joins RNA startup, MIT spinout raises $30M

September 30, 2021 bcbiotech Comments Off

While some in the life sciences industry create drugs and devices to tackle the Covid-19 pandemic, their colleagues are busy as ever raising money, testing new drugs, expanding facilities and more. Click here to view original post… […]

CENTOGENE’s Ground-Breaking Family Genetic Research Published in the New England Journal of Medicine Reveals Path to Potential Cure for Structural Birth Defects

September 30, 2021 bcbiotech Comments Off

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 29, 2021 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, announced today the publication of results from a ground-breaking global genetic study in the New England Journal of… Click here to view original post… […]

SeqLL Inc. Announces Closing of Underwriters’ Option to Purchase Additional Shares of Common Stock in Connection with its Initial Public Offering

September 30, 2021 bcbiotech Comments Off

WOBURN, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:SQL; SQLLW), a development-stage life sciences instrumentation and research services company engaged in the development of scientific assets and novel intellectual property across multiple “omics” fields, today announced the closing of the sale of an… Click here to view original post… […]

Biogen sued over kickback allegations involving MS drugs

September 29, 2021 bcbiotech Comments Off

Humana alleges that the pharma company improperly pushed those that took its multiple sclerosis drugs onto public health plans and then improperly induced payments from health plans by paying patient copays. Click here to view original post… […]

Broad researchers join a collaborative effort to improve diagnosis of rare genetic diseases

September 29, 2021 bcbiotech Comments Off

Broad researchers join a collaborative effort to improve diagnosis of rare genetic diseases Click here to view original post… […]

More setbacks for Biogen: state’s largest hospital system spurns Alzheimer’s drug

September 29, 2021 bcbiotech Comments Off

The state’s largest health care provider has declined to administer Biogen Inc.’s new Alzheimer’s drug, citing concerns over its safety and efficacy months after a controversial FDA approval. Click here to view original post… […]

Life sciences manufacturer KMC Systems opens innovation center in Cambridge

September 29, 2021 bcbiotech Comments Off

New Hampshire’s KMC Systems Inc. is headed south. The life sciences firm, which specializes in contract design and manufacturing services for medical device and diagnostics makers, has opened a 10,000-square-foot corporate innovation hub at 130 Bishop Allen Drive in Cambridge. Click here to view original post… […]